Improving ILD Diagnosis in a Multidisciplinary Discussion Team Incorporating a Genomic Classifier

Thank you

This live web event has ended. Thank you for attending.

Description

This webinar is sponsored by Veracyte

Join us on September 21 at 5:00PM EST for an insightful session with Dr. Rebecca Keith, Dr. Matthew Koslow, and Dr. William Bulman as they discuss Improving Interstitial Lung Disease Diagnosis in a Multidisciplinary Discussion Team Incorporating a Genomic Classifier. Don’t miss this opportunity to expand your knowledge and engage in an enlightening discussion with renowned experts in the field of Idiopathic Pulmonary Fibrosis and Autoimmune Lung Diseases.

By registering for this webinar, you agree your information will be shared with the sponsor.

No CME or MOC credits are available for this program.

Opinions expressed and resources shared may not have been reviewed by the ATS prior to distribution through ATS channels, or reflect official positions of the ATS, unless it is explicitly noted as a result of official ATS approval. References to specific commercial entities (companies) or products do not reflect review or endorsement by the ATS unless it is explicitly noted as a result of official ATS approval.

Contributors

Rebecca C. Keith, MD

Associate Professor
Department of Medicine
Division of Pulmonary, Critical Care & Sleep Medicine
Interstitial Lung Disease Program
National Jewish Health
Denver, CO

Rebecca C. Keith, MD is an Associate Professor in the Division of Pulmonary, Critical Care and Sleep Medicine at National Jewish Health and University of Colorado Health Sciences Center. She is the medical director for Outpatient Pulmonary Clinics at National Jewish Health. Dr. Keith earned her medical degree at The Weill Medical College of Cornell University in New York, NY. She completed her residency and chief residency in Internal Medicine at Emory University School of Medicine in Atlanta, GA, followed by her fellowship in Pulmonary and Critical Care Medicine at the University of Colorado School of Medicine in Aurora, CO. Dr. Keith aims to contribute to the understanding of the pathogenesis of Idiopathic Pulmonary Fibrosis and autoimmune lung disease via basic, translational, and clinical research with the ultimate aim to improve quality of life for patients with pulmonary fibrosis. She has a strong interest in autoimmune lung disease and the intersection between innate immunity and the development of fibrotic lung disease.
Matthew Koslow, MD

Assistant Professor
Department of Medicine
Division of Pulmonary, Critical Care & Sleep Medicine
Interstitial Lung Disease Program
National Jewish Health
Denver, CO

Matthew Koslow, MD, is the Assistant Professor of Medicine in the Division of Pulmonary, Critical Care and Sleep Medicine at National Jewish Health in Denver Colorado. Dr. Koslow received his medical degree at George Washington University School of Medicine. He completed his internal medicine residency at Montefiore Medical Center in New York and he completed his clinical fellowship in advanced lung diseases and lung transplant from the Mayo Clinic College of Medicine.Dr. Koslow’s clinical focus is with patients with autoimmune and interstitial lung diseases. He believes that knowledge and diagnostic methods continue to improve the ability to provide more precise diagnoses and therapies to preserve quality of life and prevent disease progression and that shared decision making is an integral part of effective and compassionate care.
William Bulman, MD

Medical Director, Pulmonology, (Lung Cancer and ILD)
Veracyte Inc.

Dr. Bulman is an Adjunct Associate Professor of Medicine at Columbia University and previously served as the director of Interventional Bronchoscopy at New York Presbyterian Hospital. He has worked in pulmonology for 15 years, with clinical interests in advanced diagnostic bronchoscopy and lung cancer. Dr. Bulman also served as medical director of the High-Risk Lung Nodule Assessment Center and teaches pulmonary medicine to first-year medical students at Columbia. Dr. Bulman graduated from the University of Pennsylvania School of Medicine and completed internships in both surgery and medicine before residency training in Internal Medicine. He served as a Chief Resident in Medicine and later completed fellowship training in Pulmonary and Critical Care Medicine at Columbia.

Thank you

Description

Contributors

Rebecca C. Keith, MD

Matthew Koslow, MD

William Bulman, MD